We utilized the TIMER2.0 platform to investigate the expression profiles of LAG3 in tumor tissue and normal tissue derived from TCGA datasets, thereby revealing distinct patterns of LAG3 expression across various cancer types. The gene discussed is LAG3; the disease is neoplasm.